Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2025)

Cellebrite DI (CLBT) has reported Change in Accured Expenses for 6 consecutive years, with $6.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 41.9% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $4.2 million (down 75.84% YoY), while the FY2025 annual figure was $4.2 million, down 75.84% from the prior year.
• Change in Accured Expenses came in at $6.8 million for Q4 2025 at Cellebrite DI, up from -$8.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $17.6 million in Q2 2025, with the low at -$12.2 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is $941150.0, with a median of $2.4 million recorded in 2021.
• Across the five-year window, Change in Accured Expenses surged 809.28% in 2024 and tumbled 187.46% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $2.4 million in 2021, then plunged by 184.84% to -$2.1 million in 2022, then surged by 370.44% to $5.6 million in 2023, then surged by 110.41% to $11.7 million in 2024, then tumbled by 41.9% to $6.8 million in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $6.8 million, -$8.0 million, and $17.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.